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The design and development of safe and effective multifunctional siRNA delivery systems are critical for clinical application of 
RNAi therapeutics. Here we evaluated eight new spermine-based surfactant multifunctional carriers for siRNA delivery. These 
carriers complexed with siRNA forming stable compact nanoparticles with sizes around 100 nm. The multifunctional carriers 
mediated higher intracellular siRNA transfection than Lipofectamine-2000. The siRNA nanoparticles of the multifunctional carri-
ers exhibited low cytotoxicity as shown by MTT assay. Three of the eight multifunctional carriers showed higher silencing effi-
ciency than Lipofectamine-2000 in both U87-Luc cells and CHO-GFP cells. SKAHCO showed the highest siRNA delivery effi-
ciency among the carriers. It resulted in 84.6±5.5% silencing of luciferase activity in U87-Luc cells, much higher than that (62.8± 
3.4%) from Lipofectamine-2000. In conclusion, the spermine based multifunctional carriers are promising for highly efficient 
intracellular siRNA delivery. 
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RNA interference (RNAi) is an emerging and promising 
therapeutic modality [1,2]. RNAi involves the degradation 
of an mRNA complementary to a small interfering RNA 
(siRNA) by a RNA-induced silencing complex (RISC) in 
mammalian cells. Any gene related to a human disease can 
be down-regulated by RNAi [3]. Clinical application of 
RNAi requires effective in vivo introduction of siRNA into 
the cells of interest, which still remains as the main chal-
lenge. siRNA can be encoded into plasmid DNA to deliver 
it to target cells with a viral or nonviral vector, but it is not a 
desirable approach [4,5]. Direct delivery of siRNA into cells 
is advantageous over siRNA encoding viral or plasmid 
DNA nonviral nanoparticles. siRNA can readily be synthe-
sized by chemical methods in a large scale and high purity. 
It can also be chemically modified to improve its stability 
and efficacy [6–8]. Direct siRNA delivery avoids the com-
plicated transcription procedure of a plasmid DNA and can 
induce RNAi activity in an efficient and controllable  
manner [3].  
We have recently developed pH-sensitive polymerizable 
surfactants as multifunctional carriers for nucleic acid de-
livery [9–11]. These carriers can form stable complexes 
with plasmid DNA or siRNA with sizes in the range of 
100–200 nm. The carriers are composed of a pH-sensitive 
amino head group, two distant lipid tails and two cysteinyl 
residues. With a packing parameter larger than 1, these car-
riers could transform into fusogenic inverse hexagonal con-
formation at acidic pH [12–14]. The protonation of the 
amino head group at pH lower than 6 could enhance the 
carriers’ positive charge densities and their membrane dis-
ruption abilities due to pH-sensitive amphiphilicity [15,16]. 
The thiol groups of the cysteinyl residues can be polymer-
ized through autooxidation to form disulfide bonds to fur-
ther stabilize the nanoparticles. These functions enable the 
carriers to facilitate endosomal escape of the nanoparticles 
and to release nucleic acids into cytosol via reduction of the 
disulfide bonds in the nanoparticles by cytosolic glutathione. 
The multifunctional carriers have demonstrated high intra-
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cellular and in vivo siRNA delivery efficiency, resulting in 
high intracellular gene silencing efficiency and therapeutic 
efficacy in a mouse tumor model [10,11,17,18].  
In a previous study, we reported a new series of multi-
functional carriers based on spermine with modified struc-
tures and simplified synthetic procedure for the delivery of 
nucleic acids [19]. Spermine is a natural oligoamine that can 
condense nucleic acids via charge complexation [20,21]. 
The new multifunctional carriers demonstrated the ability of 
forming stable nanoparticles with plasmid DNA at low 
concentrations, the capability of efficient intracellular trans-
fection of plasmid DNA and low cytotoxicity. In this study, 
we further investigated the effectiveness of these carriers for 
intracellular siRNA delivery. The nanoparticle formation 
between siRNA and the carriers was evaluated by dynamic 
light scattering. Intracellular siRNA delivery efficiency of 
these carriers was determined in CHO-GFP and U87-Luc 
cells with Lipofectamine-2000 as a control. The struc-
ture-activity relationship of these carriers for siRNA deliv-
ery was also evaluated. 
1  Materials and methods 
1.1  Materials 
N-(2,3-dioleoyloxy-1-propyl)trimethylammonium methyl sul-     
fate (DOTAP), bovine serum albumin (BSA), and 2,5-dip-     
henyl-3-(4,5-dimethyl-2-thiazolyl)tetrazolium bromide (MTT) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
The preparation of spermine based multifunctional carriers, 
SKCO, SKHCO, SHKCO, SHHKCO, SKACO, SKAHCO, 
SHKACO and SHHKACO, was reported in a previous lit-
erature [19]. The anti-Luc siRNA (sense sequence: 5′-CUU-     
ACGCUGAGUACUUCGAdTdT-3′; antisense sequence: 5′- 
UCGAAGUACUCAGCGUAAdTdT-3′) and anti-GFP siRNA 
(sense sequence: 5′-GCAAGCUGACCCUGAAGUUCAU-3′; 
antisense: 5′-GAACUUCAGGGUCAGCUUGCCG-3′) were 
purchased from Qiagen (Valencia, CA, USA). The human 
glioma U87 MG cell line was purchased from American 
Type Culture Collection (ATCC, Manassas, VA, USA). The 
U87 cells constantly expressing luciferase were a gift from 
Dr. Randy Jansen of the University of Utah. CHO-EGFP 
cells expressing a green fluorescent protein were kindly 
provided by Dr. Charles Roth of Rugters University.  
1.2  Particle size measurement    
The siRNA nanoparticles were prepared by mixing siRNA 
solution with spermine based surfactants at predetermined 
N/P ratios and incubated for 30 min. The size of the nano-
particles was analyzed using a Brookhaven Instruments 
BI-200SM equipped with a 5 mW helium-neon laser with 
output at 633 nm. Measurements were performed at room 
temperature in triplicates. The effective diameters of the 
nanoparticles were computed using the software provided 
by the manufacturer of the instrument.  
1.3  Surfactant mediated intracellular siRNA uptake 
Approximately 3×105 U87 cells per well were plated in 
12-well plates. After 24 h, the nanoparticles, which were 
prepared by mixing 1 g AlexaFluor 488 labeled all nega-
tive siRNA (Qiagen) with each of multifunctional carriers at 
an N/P ratio of 12 or Lipofectamine-2000 for 30 min, were 
added into each well and incubated for 4 h at 37°C in 1 mL 
serum free medium. The medium was removed and the cells 
were washed twice with PBS and then trypsinized. The cells 
were collected and fixed by 4% paraformaldehyde in PBS 
for 20 min. The samples were analyzed using a FACSCali-
bur flow cytometer (BD Bioscience) with FL-1 channel fo-
cused on the green fluorescence of AlexaFluor 488. Results 
were analyzed using Cell-Quest (BD Bioscience) software.  
1.4  Surfactants mediated silencing of luciferase with 
siRNA  
U87-Luc cells were seeded in 96 well plates at a density of 
5×103 cells/well in DMEM medium containing 10% FBS, 
G418 (300 g/mL), streptomycin (100 g/mL) and penicillin 
(100 units/mL) 24 h prior to transfection. Anti-Luc siRNA 
was complexed with multifunctional carriers at an N/P ratio 
of 12 or Lipofectamine-2000 for 30 min and then incubated 
with cells at a siRNA concentration of 50 nmol/L for 4 h at 
37°C in serum free DMEM medium. The medium was then 
replaced with complete DMEM medium and incubated for 
an additional 44 h. Cells were washed with pre-warmed 
PBS, and treated with 200 L/well lysis buffer followed by 
a freeze-thaw cycle. Luciferase activity in cell lysates was 
then measured by a luciferase assay kit (Promega, Madison, 
WI, USA) on a luminometer (Dynex Tech., Chantilly, VA, 
USA). The gene silencing efficiency was normalized 
against the luciferase activity of untreated cells. 
1.5  Surfactants mediated GFP silencing with siRNA 
CHO-GFP cells were cultured in F12-K medium. Cells were 
seeded into 12-well plates at the density of 2×105 cells per 
well and further cultured overnight. Nanoparticles formed 
by mixing 1.0 g anti-GFP siRNA with multifunctional car-
riers at an N/P ratio of 12 or Lipofectamine-2000 for 30 min 
at room temperature. The formed nanoparticles were then 
added to CHO-GFP cells in serum free F-12K medium at a 
siRNA concentration of 34 nmol/L. After 4 h incubation at 
37°C, the medium was replaced with fresh complete F12-K 
medium and cultured for an additional 20 h. Cells were then 
washed with pre-warmed PBS, harvested through trypsini-
zation, and fixed in cold PBS containing 4% paraformalde-
hyde for 20 min. Samples were analyzed using a FACSCal-
ibur flow cytometer with FL-1 channel focused on green flu-
orescence. Results were analyzed using Cell-Quest software.  
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1.6  Cytotoxicity study of siRNA/multifunctional carri-
er nanoparticles 
The cytotoxicity of siRNA/multifunctional carrier nanopar-
ticles was evaluated by an MTT assay in U87 cells. Briefly, 
U87 cells were plated in 96-well plates with 1×104 cells per 
well and cultured overnight. Anti-Luc siRNA (10 pmol) 
was mixed with multifunctional carriers at an N/P ratio of 
12 or Lipofectamine-2000 at a predetermined dose and in-
cubated at room temperature for 30 min to form nanoparti-
cles. The formed nanoparticles were then added into serum- 
free MEM medium to reach a final concentration of 50 nmol/L 
siRNA and incubated with U87 cells for 4 h. The medium 
was then replaced with complete MEM medium and con-
tinued culturing for an additional 20 h. The medium was 
removed and cells were digested by 200 L DMSO. The 
absorption was read at 570 nm using a plate reader (Model 
680, Bio-Rad, Hercules, CA, USA). The relative cell viability 
was calculated by the equation: ([Abs]sample[Abs]blank)/ 
([Abs]control[Abs]blank)×100%.  
2  Results and discussion 
The chemical structures of the spermine-based surfactants,  
SKCO, SKHCO, SHKCO, SHHKCO, SKACO, SKAHCO, 
SHKACO and SHHKACO, are shown in Figure 1. All of 
spermine based multifunctional carriers formed stable na-
noparticles with siRNA at low concentrations. The size of 
nanoparticles at N/P ratio 12 was in the range of 85.5 nm 
(SKHCO) and 120.6 nm (SKAHCO) as determined by dy-
namic light scattering (Figure 2). The combination of charge 
complexation of siRNA and the spermine head group, hy-
drophobic condensation of oleoyl lipid tails and oxidation of 
the dithiols resulted in the formation of compact siRNA 
nanoparticles.  
The spermine based multifunctional carriers mediated 
high intracellular delivery efficiency of AlexaFluor 488 
labeled siRNA. Figure 3 shows flow cytometric diagrams of 
the uptake of the labeled siRNA in U87 cells mediated by 
various carriers at an N/P ratio of 12. The multifunctional 
carriers resulted in approximately 91% to 96% siRNA 
transfection in U87 cells, while Lipofectamine-2000 only 
transfected 73% of cells under the same condition. It appears 
that the carriers SKHCO, SKCO and SHHKCO with a lysine 
“Y” joint were lightly more effective intracellular siRNA 
delivery than the corresponding SKAKCO, SKACO and 
SHHKACO with a lysyl--alanine joint.  
Figure 4 shows the efficiency of silencing luciferase ex-
pression in U87-Luc cells by an anti-Luc siRNA mediated  
 
Figure 1  Chemical structures of the spermine based lipid surfactants.
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Figure 2  The size of the siRNA nanoparticles with the spermine based 
multifunctional carriers at an N/P ratio of 12 (n=3).  
by the carriers. SKHCO, SHHKCO, SKAHCO, SKACO 
and SHKACO resulted in higher luciferase silencing efficiency 
than Lipofectamine-2000. Among these carriers, SKAHCO 
showed the highest gene silencing efficiency (84.6±5.5%) at 
50 nmol/L siRNA and N/P ratio of 12. The gene silencing 
efficiency mediated by the carriers was further determined 
in CHO-GFP cells with an anti-GFP siRNA. Figure 5 shows 
flow cytometric diagrams of CHO-GFP cells after the treat-
ment with the nanoparticles of an anti-GFP siRNA and var-
ious carriers. SKAHCO at N/P ratio 12 again mediated the 
highest GFP silencing efficiency (61%). SHKACO (49%), 
SKHCO (49%) and SKACO (51%) also resulted in better  
 
Figure 3  Flow cytometric diagrams showing cellular uptake of siRNA 
mediated by the multifunctional carriers in the U87 cells with Lipofectamine 
2000 (Lipo-2000) as a control. 
 Xu R Z, et al.   Chin Sci Bull   November (2012) Vol.57 No.31 3983 
 
 
Figure 4  Silencing efficiency of luciferase expression in U87-Luc cells 
mediated by the nanoparticles of an anti-Luc siRNA (50 nmol/L) with the 
multifunctional carriers. The relative gene silencing efficiency was nor-
malized to untreated cells. 
GFP silencing than Lipofectamine-2000 (40%). 
Figure 6 shows the viability of U87 cells treated with the 
siRNA nanoparticles of the spermine based siRNA nanopar-
ticles at N/P of 12. The MTT assay showed that the siRNA 
nanoparticles of the carriers resulted in low cytotoxicity at 
50 nmol/L siRNA. The SKAHCO/siRNA nanoparticles 
with the highest gene silencing efficiency caused little cy-
totoxicity. The cytotoxicity of the siRNA nanoparticles of 
the multifunctional carriers was comparable with that of the 
siRNA complexes of Lipofectamine-2000. 
The use of RNAi to treat human diseases requires the deliv-
ery of therapeutic siRNA into target cells. The design and 
development of safe and effective siRNA delivery system is a 
key step towards to clinical application of RNAi therapeutics. 
The delivery systems should be able to protect siRNA from  
 
Figure 5  Flow cytometric 
diagrams showing GFP silencing 
in CHO-GFP cells mediated by 
the nanoparticles of an anti-GFP 
siRNA (100 nmol/L) with the 
multifunctional carriers.  
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Figure 6  Cytotoxicity of the siRNA nanoparticles with the multifunc-
tional carriers at an N/P ratio of 12 in U87 cells. siRNA concentration was 
50 nmol/L. Lipofectamine 2000 (Lipo-2000) was used as control. 
enzymatic degradation during delivery process [22], to de-
liver siRNA into targets cells and to release it into cytosol. In 
this study, we evaluated the efficacy of eight new spermine 
based surfactants as the multifunctional carriers for siRNA 
delivery. These carriers were able to form stable and com-
pact nanoparticles with siRNA and resulted in high intra-
cellular siRNA uptake. Six carriers contained one or two 
histidine residuals. The imidazole group in histidine had a 
pKa around 6.5 and was expected to facilitate endosomal 
escape of the siRNA nanoparticles at endosomal pH for 
enhanced gene silencing. However, SHHKACO with two 
histidine residues mediated the lowest gene silencing effi-
ciency in both U87-Luc and CHO-GFP cells among the 
carriers. The other histidine containing carriers did not have 
any advantage over the carriers without histidine, SKACO 
and SKCO. The carriers SKACO, SKAHCO, SHKACO and 
SHHKACO had a more symmetric location of lipid tails 
than SKCO, SKHCO, SHKCO and SHHKCO. It appears 
that the location of the lipid tails did not have a significant 
impact on intracellular siRNA uptake and gene silencing 
efficiency mediated by the surfactants. Nevertheless, three 
carriers, SKAHCO, SKHCO and SKACO, were more ef-
fective than Lipofectamine-2000 in silencing the expression 
of both luciferase and GFP. Overall, SKACO demonstrated 
the highest intracellular plasmid DNA delivery efficiency as 
shown in the previous study [19] and SKAHCO showed the 
highest siRNA delivery efficiency.  
3  Conclusion 
The spermine based surfactants formed stable nanoparticles 
with siRNA at an N/P ratio of 12. The nanoparticles had 
relatively low cytotoxicity and resulted in high intracellular 
uptake of AlexaFluor488-labeled siRNA. Five of these car-
riers possessed a higher overall luciferase activity knock-
down efficiency than Lipofectamine-200 when delivering  
anti-Luc siRNA. Four of these multifunctional carriers showed 
a higher GFP silencing efficiency than Lipofectamine-2000. 
Among these tested carriers, SKAHCO demonstrated the 
highest intracellular siRNA delivery efficiency. It has a 
great potential for safe and effective siRNA delivery. 
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